AMRX vs. FXAIX
Compare and contrast key facts about Amneal Pharmaceuticals, Inc. (AMRX) and Fidelity 500 Index Fund (FXAIX).
FXAIX is a passively managed fund by Fidelity that tracks the performance of the S&P 500 Index. It was launched on Feb 17, 1988.
Performance
AMRX vs. FXAIX - Performance Comparison
Loading graphics...
AMRX vs. FXAIX - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
AMRX Amneal Pharmaceuticals, Inc. | -1.35% | 59.09% | 30.48% | 205.03% | -58.46% | 4.81% | -5.19% | -64.38% | -18.74% | 25.66% |
FXAIX Fidelity 500 Index Fund | -7.05% | 17.84% | 25.01% | 26.29% | -18.14% | 28.71% | 18.42% | 31.48% | -4.43% | 21.82% |
Returns By Period
In the year-to-date period, AMRX achieves a -1.35% return, which is significantly higher than FXAIX's -7.05% return. Over the past 10 years, AMRX has underperformed FXAIX with an annualized return of -9.37%, while FXAIX has yielded a comparatively higher 13.75% annualized return.
AMRX
- 1D
- 4.02%
- 1M
- -9.99%
- YTD
- -1.35%
- 6M
- 24.18%
- 1Y
- 48.33%
- 3Y*
- 107.56%
- 5Y*
- 13.50%
- 10Y*
- -9.37%
FXAIX
- 1D
- -0.39%
- 1M
- -7.68%
- YTD
- -7.05%
- 6M
- -4.59%
- 1Y
- 14.42%
- 3Y*
- 17.17%
- 5Y*
- 11.40%
- 10Y*
- 13.75%
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
AMRX vs. FXAIX — Risk / Return Rank
AMRX
FXAIX
AMRX vs. FXAIX - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Amneal Pharmaceuticals, Inc. (AMRX) and Fidelity 500 Index Fund (FXAIX). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
| AMRX | FXAIX | Difference | |
|---|---|---|---|
Sharpe ratioReturn per unit of total volatility | 1.46 | 0.84 | +0.62 |
Sortino ratioReturn per unit of downside risk | 2.01 | 1.30 | +0.72 |
Omega ratioGain probability vs. loss probability | 1.25 | 1.20 | +0.05 |
Calmar ratioReturn relative to maximum drawdown | 2.27 | 1.05 | +1.21 |
Martin ratioReturn relative to average drawdown | 6.35 | 5.13 | +1.22 |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Loading graphics...
Sharpe Ratios by Period
| AMRX | FXAIX | Difference | |
|---|---|---|---|
Sharpe Ratio (1Y)Calculated over the trailing 1-year period | 1.46 | 0.84 | +0.62 |
Sharpe Ratio (5Y)Calculated over the trailing 5-year period | 0.27 | 0.68 | -0.41 |
Sharpe Ratio (10Y)Calculated over the trailing 10-year period | -0.14 | 0.77 | -0.91 |
Sharpe Ratio (All Time)Calculated using the full available price history | 0.10 | 0.75 | -0.65 |
Correlation
The correlation between AMRX and FXAIX is 0.37, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.
Dividends
AMRX vs. FXAIX - Dividend Comparison
AMRX has not paid dividends to shareholders, while FXAIX's dividend yield for the trailing twelve months is around 1.20%.
| TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
AMRX Amneal Pharmaceuticals, Inc. | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
FXAIX Fidelity 500 Index Fund | 1.20% | 1.11% | 1.25% | 1.45% | 1.69% | 1.22% | 1.60% | 2.06% | 2.72% | 1.97% | 2.52% | 2.83% |
Drawdowns
AMRX vs. FXAIX - Drawdown Comparison
The maximum AMRX drawdown since its inception was -97.52%, which is greater than FXAIX's maximum drawdown of -33.79%. Use the drawdown chart below to compare losses from any high point for AMRX and FXAIX.
Loading graphics...
Drawdown Indicators
| AMRX | FXAIX | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -97.52% | -33.79% | -63.73% |
Max Drawdown (1Y)Largest decline over 1 year | -22.12% | -12.13% | -9.99% |
Max Drawdown (5Y)Largest decline over 5 years | -81.38% | -24.50% | -56.88% |
Max Drawdown (10Y)Largest decline over 10 years | -96.51% | -33.79% | -62.72% |
Current DrawdownCurrent decline from peak | -75.77% | -8.89% | -66.88% |
Average DrawdownAverage peak-to-trough decline | -54.10% | -3.83% | -50.27% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 7.90% | 2.50% | +5.40% |
Volatility
AMRX vs. FXAIX - Volatility Comparison
Amneal Pharmaceuticals, Inc. (AMRX) has a higher volatility of 11.31% compared to Fidelity 500 Index Fund (FXAIX) at 4.24%. This indicates that AMRX's price experiences larger fluctuations and is considered to be riskier than FXAIX based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading graphics...
Volatility by Period
| AMRX | FXAIX | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 11.31% | 4.24% | +7.07% |
Volatility (6M)Calculated over the trailing 6-month period | 23.01% | 9.08% | +13.93% |
Volatility (1Y)Calculated over the trailing 1-year period | 33.25% | 18.13% | +15.12% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 51.16% | 16.88% | +34.28% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 65.30% | 18.03% | +47.27% |